The BareStory
Financial markets are preparing for a significant week marked by the start of corporate earnings season and the annual JPMorgan Healthcare Conference in San Francisco. The healthcare event is expected to set the tone for the industry in 2026, with analysts anticipating a wave of announcements regarding corporate mergers and acquisitions.
Within the pharmaceutical sector, the focus has reportedly shifted away from drug pricing concerns following agreements reached in late 2025 between President Donald Trump and major manufacturers, including Eli Lilly and Novo Nordisk. Instead, industry attention is turning toward looming patent expirations, which threaten an estimated $300 billion in revenue by the end of the decade. JPMorgan analysts have highlighted Bristol Myers Squibb’s high exposure to this cycle and Merck’s efforts to manage exclusivity losses for its key cancer drug. The obesity drug market also remains a central theme, with Novo Nordisk and Eli Lilly expected to address new oral treatments and insurance coverage dynamics.
In the broader market, commentator Jim Cramer noted a rotation of capital out of previous market leaders, such as Apple and Nvidia, into overlooked sectors like data storage. Cramer stated that while the investment cases for these tech giants remain intact, they are currently being sold to fund opportunities elsewhere. The reporting period begins Tuesday, with results expected from major financial institutions, including JPMorgan Chase, Citigroup, and Wells Fargo, as well as Delta Air Lines.
How it may affect me
As a U.S. reader:
You may gain access to new oral obesity treatments or see shifts in insurance coverage as companies like Eli Lilly and Novo Nordisk address these market dynamics.
Your investment portfolio may be impacted by capital rotation as investors move funds from tech leaders like Apple and Nvidia into overlooked sectors such as data storage.
You might see pharmaceutical companies shift focus away from drug pricing concerns following agreements with the administration, turning attention instead to mergers and patent expirations.
You could see market volatility or new economic signals as major banks and Delta Air Lines kick off the corporate earnings season with their financial reports.
